NEW YORK, Oct. 8 (GenomeWeb News) – Chicago-based Nanosphere today announced that it has licensed a detection technology for protein analytes from Northwestern University.
The technology was developed by Nanosphere co-founder and Northwestern University professor Chad Merkin and described in the Sept. 26 issue of Science .
Financial details of the licensing deal were not disclosed.
The method is based on magnetic microparticle probes with antibodies that specifically bind a target of interest and nanoparticle probes that are encoded with DNA that is unique to the protein target of interest and antibodies that can sandwich the target captured by the probes, the article says.
The technology was first applied to detecting prostate specific antigen.
The company said it plans to combine the technology with its detection systems for DNA.